Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Congress December 4-7 in Florence, Italy

CAMBRIDGE, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) — Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from its clinical studies of investigational oral gildeuretinol for the treatment of Stargardt disease and Geographic Atrophy (GA) will be presented at the 13th International FLORetina […]

KraneShares Dragon Capital Vietnam Growth Index ETF (Ticker: KPHO) Lists on the New York Stock Exchange

(NYSE:KPHO), NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — KraneShares, a leading global asset manager known for its innovative exchange-traded funds (ETFs), today announced the launch of the KraneShares Dragon Capital Vietnam Growth Index ETF (Ticker: KPHO). KPHO provides investors with targeted exposure to Vietnamese companies selected using a fundamental and proprietary growth methodology within

Perma-Fix and Enforcer One Announce Joint Distribution Agreement to Deliver End-to-End PFAS Foam Transition Solutions

(NASDAQ:PESI), ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced a joint distribution agreement with Enforcer One, LLC (“Enforcer One”), a U.S.-based manufacturer of FIREBULL(R) fluorine-free firefighting agents and Enforcer(R) brand compressed air foam systems (CAFS). The collaboration is designed to provide fire departments, industrial facilities, airports,

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop

(NASDAQ:VERU), MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced multiple presentations at The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) 18th International Conference, and the SCWD's Regulatory and Clinical

Foremost Clean Energy Announces Upcoming Ground-Based Gravity Survey at its Hatchet Lake Uranium Project, Athabasca Basin, Saskatchewan

(NASDAQ:FMST),(CNSX:FAT.CN),(NASDAQ:FMSTW),(Frankfurt:F0R),(Frankfurt:F0R.F), VANCOUVER, British Columbia, Dec. 04, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce a ground-based gravity survey will commence in December over its Hatchet Lake Uranium Property (“Hatchet“), located in the eastern Athabasca Basin region ( the “Basin“) of northern Saskatchewan (see

DeFi Development Corp. Announces Strategic Partnership with Perena to Leverage USD* Stablecoin Yield for SPS Growth

(NASDAQ:DFDV), BOCA RATON, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic partnership with Perena, a stablebank built to deliver high yield on stable assets on

Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for MCS‒2 Market Entry

(NasdaqGM:MENS), New Taipei City, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets

Medera to Participate in Oppenheimer Movers in Rare Disease Summit 2025

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that James Kim, Chief Corporate Officer of Medera, will participate in the Oppenheimer Movers in Rare Disease Summit on Thursday, December 11, 2025, at the Sofitel New York, 45 West

Live Ventures to Issue Fiscal Year End 2025 Financial Results and Hold Earnings Conference Call on December 11, 2025

(NASDAQ:LIVE), LAS VEGAS, Dec. 04, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal year ended September 30, 2025, before the market opens on Thursday, December 11, 2025. The Company will hold a conference call to discuss the

Duke Robotics Advances U.S. Market Readiness Efforts to Support Commercial Expansion of IC Drone Technology

(OTCQB:DUKR),(OTC US:DUKR), Readiness efforts mark an important step in preparing the IC Drone for potential deployment in the U.S., aligning Duke Robotics' technology with U.S. National Defense requirements while providing a platform to expand market penetration The Company is positioning the IC Drone to support rising national priorities around grid resilience and energy-infrastructure security, underscored

Scroll to Top